Praxis Precision Medicines, Inc.PRAXEarnings & Financial Report

Nasdaq · pharmaceutical industry

Wyeth Pharmaceuticals Inc. was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

Revenue

Gross Profit

N/A

Operating Profit

$-78.4M

Net Profit

$-73.9M

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

YoY Growth

N/A

EPS

$-3.36

Praxis Precision Medicines, Inc. Q3 2025 Financial Summary

Praxis Precision Medicines, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-73.9M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.

Key Financial Metrics

Total Revenue	$0
Net Profit	$-73.9M
Gross Margin	N/A
Operating Margin	N/A
Report Period	Q3 2025

Praxis Precision Medicines, Inc. Annual Revenue by Year

Praxis Precision Medicines, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $8.6M).

Year	Annual Revenue
2024	$8.6M
2023	$2.4M
2022	$0

Income Statement

	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Revenue	$515000	$431000	$357000	$302000	$7.5M	$0	$0	$0
YoY Growth	N/A	-36.9%	-54.3%	-35.5%	1349.1%	N/A	N/A	N/A

Balance Sheet

	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Assets	$87.9M	$250.4M	$441.1M	$416.3M	$483.1M	$478.7M	$452.8M	$396.4M
Liabilities	$18.3M	$20.7M	$22.0M	$33.6M	$37.7M	$39.5M	$48.6M	$52.9M
Equity	$69.7M	$229.7M	$419.1M	$382.7M	$445.4M	$439.2M	$404.2M	$343.5M